HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 80 filers reported holding HARVARD BIOSCIENCE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $478,000 | -64.2% | 77,034 | -59.4% | 0.00% | -50.0% |
Q4 2021 | $1,336,000 | -12.0% | 189,547 | -12.9% | 0.00% | 0.0% |
Q3 2021 | $1,519,000 | -45.5% | 217,619 | -34.9% | 0.00% | -33.3% |
Q2 2021 | $2,786,000 | +161.6% | 334,439 | +71.5% | 0.00% | +200.0% |
Q1 2021 | $1,065,000 | +24.6% | 194,970 | -2.2% | 0.00% | 0.0% |
Q4 2020 | $855,000 | +42.5% | 199,370 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $600,000 | +209.3% | 199,370 | +218.9% | 0.00% | – |
Q2 2020 | $194,000 | +312.8% | 62,514 | +193.5% | 0.00% | – |
Q1 2020 | $47,000 | -27.7% | 21,300 | 0.0% | 0.00% | – |
Q4 2019 | $65,000 | 0.0% | 21,300 | 0.0% | 0.00% | – |
Q3 2019 | $65,000 | -52.2% | 21,300 | -32.4% | 0.00% | – |
Q1 2019 | $136,000 | +7.9% | 31,492 | -20.3% | 0.00% | – |
Q4 2018 | $126,000 | -39.1% | 39,503 | 0.0% | 0.00% | – |
Q3 2018 | $207,000 | +53.3% | 39,503 | +56.7% | 0.00% | – |
Q2 2018 | $135,000 | +7.1% | 25,203 | 0.0% | 0.00% | – |
Q1 2018 | $126,000 | – | 25,203 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engine Capital Management, LP | 3,542,852 | $10,536,000 | 4.92% |
Fondren Management LP | 865,000 | $2,660,000 | 2.21% |
Harvey Partners, LLC | 742,500 | $2,283,000 | 1.65% |
BARD ASSOCIATES INC | 311,922 | $959,000 | 0.49% |
Adirondack Research & Management Inc. | 131,042 | $403,000 | 0.35% |
Granahan Investment Management | 1,771,964 | $5,449,000 | 0.30% |
DALTON GREINER HARTMAN MAHER & CO | 1,373,518 | $4,224,000 | 0.29% |
HEARTLAND ADVISORS INC | 1,000,000 | $3,075,000 | 0.24% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 499,616 | $1,536,000 | 0.22% |
Alambic Investment Management, L.P. | 43,569 | $134,000 | 0.10% |